Evaluate the safety of drug regimens consisting of ampicillin, metronidazole, clindamycin, and piperacillin-tazobactam in infants with complicated intra-abdominal infections.

Ended Awarded Last action

Contract number
HHSN27500025
Awardee
Awarding agency
Obligated
$6,417,958

Award facts

Contract value 100% obligated
$6,417,958.42 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
PSC
AN12 Health R&D Services; Health Care Services; Applied Research
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Cost No Fee
Place of performance
Durham, NC 27705, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Close Out P00006 $0
Other Administrative Action P00005 -$901,309
Other Administrative Action 4 -$443,707
Other Administrative Action 3 $0
Other Administrative Action 2 $0
Change Order 1 $1,570,259
Original award $6,192,715

Quick answers

Who was awarded contract HHSN27500025?

HHSN27500025 was awarded to Duke University by National Institute of Child Health and Human Development (National Institutes of Health) on September 24, 2013.

How much is contract HHSN27500025 worth?

The government has obligated $6,417,958 on HHSN27500025.

Is contract HHSN27500025 an order under another contract?

Yes. HHSN27500025 is a delivery order under HHSN275201000003I, an indefinite delivery contract.

Was contract HHSN27500025 competed?

The extent of competition for HHSN27500025 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award